
The study evaluated the prognostic value of the myocardial performance score (MPS) in heart failure (HF) patients. A total of 709 patients who underwent right heart catheterization for chronic or acute-on-chronic HF were analyzed. MPS, calculated using the aortic pulsatility index and cardiac power output, was categorized into three groups: MPS <0.5, 0.5-1.0, and ≥1.0. Over two years, patients with MPS <0.5 had a significantly higher risk of adverse outcomes (death or need for a left ventricular assist device/heart transplant) compared to those with MPS ≥1.0. MPS was a superior prognostic indicator over traditional hemodynamic measures such as pulmonary capillary wedge pressure and cardiac index. MPS provides enhanced risk stratification and can improve long-term outcome predictions in HF management.
Like
Save
Share